Hormone therapy use and prescription durations of menopausal women in Taiwan: A 5 years' National Cohort study

Maturitas

Volumn 58, Issue 3, 2007, Pages 259-268

  Kuo, De Jhen ^a,b   Lee, Yue Chune ^b   Huang, Weng Foung ^b  

^a TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

^b Departments of Medicine   (Taiwan)

Author keywords

Cohort study; Hormone replacement therapy; Menopausal syndrome; Prescription pattern; Taiwan; Utilization

Indexed keywords

ALLYLESTRENOL; DYDROGESTERONE; GESTRINONE; LYNESTRENOL; MEDROGESTONE; MEDROXYPROGESTERONE; NORETHISTERONE; NORETHISTERONE ACETATE; NORGESTREL; PROGESTERONE;

ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OUTPATIENT; PRESCRIPTION; PREVALENCE; REGISTER; TAIWAN; TREATMENT DURATION;

ADULT; AGED; COHORT STUDIES; DIAGNOSIS-RELATED GROUPS; DRUG UTILIZATION REVIEW; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; REGISTRIES; TAIWAN;

EID: 36049016469     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.08.013     Document Type: Article

References (23)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 3-33
2. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362 (2003) 419-427
3. Lawton B., and Utian W.H. Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users. BMJ 327 (2003) 845-846
4. Mishra G., Kok H., Ecob R., Cooper R., Hardy R., and Kuh D. Cessation of hormone replacement therapy after reports of adverse findings from randomized controlled trials: evidence from a British birth cohort. Am J Public Health 96 (2006) 1219-1225
5. Van den Berg L.T.W.T.d.J., Faber A., and Van den Berg P.B. HRT use in 2001 and 2004 in The Netherlands-a world of difference. Maturitas 54 (2006) 193-197
6. Huang W.F., Tsai Y.W., Hsiao F.Y., and Liu W.C. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan. BMC Public Health 7 (2007) 56
7. Hersh A.L., Stefanick M.L., and Stafford R.S. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 292 (2004) 47-53
8. Chang C., and Chang C.H. Menopause and hormone using experiences of Chinese women in Taiwan. Health Care Women Int 17 (1996) 307-318 (in Chinese)
9. Chang C., and Chang C.C. Medicalization of women's health: menopause/climacteric as an example. Women Gend 9 (1998) 145-185 (in Chinese)
10. Fuh J.L., Wand S.J., Lu S.R., Juang K.D., and Chiu L.M. The Kinmen women-health investigation (KIWI): a menopausal study of a population aged 40-54. Maturitas 39 (2001) 117-124
11. Chung D.T., Cheng W.T., Liu Y.L., and Cheng S.P. The status of hormone replacement therapy among women in the clinic of health station of Jin-San hsiang. J Med Sci 21 (2001) S99-S106 (in Chinese)
12. Pan H.A., Wu M.H., Hsu C.C., Yao B.L., and Huang K.E. The perception of menopause among women in Taiwan. Maturitas 41 (2002) 269-274
13. Cheng M.H., Wang S.J., Wang P.H., and Fuh J.L. Attitudes toward menopause among middle-aged women: a community survey in an island of Taiwan. Maturitas 52 (2005) 348-355
14. Huh J.L., Wang S.J., Lee S.J., Lu S.R., and Juang K.D. A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 53 (2006) 447-453
15. National Health Research Institutes (NHRI). National Health Insurance Database http://www.nhri.org.tw/nhird/index.php/(in Chinese).
16. Rosner B. Fundamentals of biostatistics. 2nd ed. (1987), Harvard University Press, Boston pp. 304-305
17. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized liner models. Biometrika 73 (1986) 13-22
18. Taipei Association for the Promotion of Women's Right. http://tapwer.womenweb.org.tw/english/english.htm.
19. Taiwan Women's Link. http://twl.ngo.org.tw/health/health00-1.htm.
20. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
21. Eden J. Progestin in breast cancer. Am J Obstet Gynecol 5 (2003) 1123-1131
22. Ng H.T. The impact of hormone replacement therapy: a critical review. zhong hua min guo fu ai yi xue za zhi (J gynecol Oncol Rep China) 1 (2004) 19-31 (in Chinese)
23. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-613